These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25817448)

  • 1. [Fever induced by hydroxycarbamide].
    Lizarralde Palacios E; Gutiérrez Macías A; Rámiz Martínez M; Escalante Boleas M
    Med Clin (Barc); 2015 Dec; 145(11):505-6. PubMed ID: 25817448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced fever caused by hydroxyurea. Apropos of 3 new cases].
    Gallant C; Vial T; Allochon Y; Monier JM; Blanc M; Evreux JC
    Ann Med Interne (Paris); 1998 Mar; 149(2):59-61. PubMed ID: 11490525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea-induced fever and hepatitis.
    Westerman DA; Schwarer A; Grigg AP
    Aust N Z J Med; 1998 Oct; 28(5):657-9. PubMed ID: 9847957
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea as a cause of drug fever.
    Braester A; Quitt M
    Acta Haematol; 2000; 104(1):50-1. PubMed ID: 11111124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unwanted side effect of hydroxyurea.
    Najean Y
    Ann Hematol; 1996 Feb; 72(2):101. PubMed ID: 8597606
    [No Abstract]   [Full Text] [Related]  

  • 6. Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?
    Marcellino B; Hoffman R; Mascarenhas J
    Leuk Res; 2019 Jan; 76():94-95. PubMed ID: 30501902
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
    Quintás-Cardama A; Pérez-Encinas M; Gonzalez S; Bendaña A; Bello JL
    Ann Hematol; 1999 Apr; 78(4):187-8. PubMed ID: 10348150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea.
    van den Anker-Lugtenburg PJ; Sizoo W
    Am J Hematol; 1990 Feb; 33(2):152. PubMed ID: 2301374
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
    [No Abstract]   [Full Text] [Related]  

  • 10. Fever caused by hydroxyurea.
    Bauman JL; Shulruff S; Hasegawa GR; Roden R; Hartsough N; Bauernfeind RA
    Arch Intern Med; 1981 Feb; 141(2):260-1. PubMed ID: 7458524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia.
    Barosi G
    Eur J Haematol Suppl; 2007 Oct; (68):24-6. PubMed ID: 17727562
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea-induced fever: case report and review of the literature.
    Lossos IS; Matzner Y
    Ann Pharmacother; 1995 Feb; 29(2):132-3. PubMed ID: 7756710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
    Jabr FI; Shamseddine A; Taher A
    Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia.
    Francis S; Bareford D; Baggott C; Thachil J
    Leuk Res; 2012 Apr; 36(4):488-90. PubMed ID: 22196956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The indolent natural history of essential thrombocythemia: a challenge to new drug development.
    Tefferi A
    Mayo Clin Proc; 2005 Jan; 80(1):97-8. PubMed ID: 15667035
    [No Abstract]   [Full Text] [Related]  

  • 17. Nail changes after chemotherapy.
    Las Heras G; Juncà Piera J
    Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma following essential thrombocythemia.
    Ben Youssef Y; Gmidène A; Bouabid Z; Bouallegui S; Sriha B; Zaier M; Sennana H; Khelif A
    Ann Biol Clin (Paris); 2013; 71(4):457-60. PubMed ID: 23906574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Essential thrombocythemia associated with incomplete type intestinal Behçet disease during hydroxyurea treatment].
    Kobune M; Kato J; Kuribayashi K; Iyama S; Fujimi A; Murase K; Ueno A; Kikuchi S; Satoh T; Okamoto T; Takimoto R; Matsunaga T; Niitsu Y
    Rinsho Ketsueki; 2005 Oct; 46(10):1136-40. PubMed ID: 16440777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever attributed to the use of hydroxyurea.
    in 't Veld BA; Slappendel AM; Feenstra J; Veen C; van Aken J; Runhaar EA; Stricker BH
    Neth J Med; 1997 Sep; 51(3):110-3. PubMed ID: 9360411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.